Cargando…

Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer

SIMPLE SUMMARY: Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage lung cancer. The purpose of this study was to investigate the optimal dose distribution and prognostic factors for local control (LC) in 100 patients with lung cancer who underwent SBRT. The 1- and 3-year LC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inagaki, Takaya, Doi, Hiroshi, Ishida, Naoko, Ri, Aritoshi, Tatsuno, Saori, Wada, Yutaro, Uehara, Takuya, Inada, Masahiro, Nakamatsu, Kiyoshi, Hosono, Makoto, Nishimura, Yasumasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870557/ https://www.ncbi.nlm.nih.gov/pubmed/35205682 http://dx.doi.org/10.3390/cancers14040933

Ejemplares similares

Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors
por: Uehara, Takuya, et al.
Publicado: (2021)

Dosimetric Evaluation of Simplified Knowledge-Based Plan with an Extensive Stepping Validation Approach in Volumetric-Modulated Arc Therapy-Stereotactic Body Radiotherapy for Lung Cancer
por: Wada, Yutaro, et al.
Publicado: (2021)

Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy
por: Anami, Shimpei, et al.
Publicado: (2019)

Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer
por: Tatsuno, Saori, et al.
Publicado: (2022)

Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy
por: Inada, Masahiro, et al.
Publicado: (2017)

Influence of Cleaned-up Commercial Knowledge-Based Treatment Planning on Volumetric-Modulated Arc Therapy of Prostate Cancer
por: Tamura, Mikoto, et al.
Publicado: (2020)

A novel radiation-shielding undergarment using tungsten functional paper for patients with permanent prostate brachytherapy
por: Inada, Masahiro, et al.
Publicado: (2018)

Feasibility study of volumetric modulated arc therapy with Halcyon™ linac for total body irradiation
por: Uehara, Takuya, et al.
Publicado: (2021)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer
por: Tamura, Mikoto, et al.
Publicado: (2018)

Dose–volume histogram analysis and clinical evaluation of knowledge-based plans with manual objective constraints for pharyngeal cancer
por: Uehara, Takuya, et al.
Publicado: (2020)

Maximum kinetic energy considerations in proton stereotactic radiosurgery
por: Sengbusch, Evan R., et al.
Publicado: (2011)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
por: Grzbiela, Hanna, et al.
Publicado: (2023)

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
por: Takeda, Atsuya, et al.
Publicado: (2014)

Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy
por: Wang, Shuo, et al.
Publicado: (2019)

Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors
por: Ando, Yuichi, et al.
Publicado: (2014)

Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
por: Cilla, Savino, et al.
Publicado: (2020)

An updating approach for knowledge‐based planning models to improve plan quality and variability in volumetric‐modulated arc therapy for prostate cancer
por: Nakamura, Kenji, et al.
Publicado: (2021)

Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size
por: Hattori, Aritoshi, et al.
Publicado: (2022)

A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
por: Meyer, Jeffrey J., et al.
Publicado: (2015)

Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy
por: Panizza, Denis, et al.
Publicado: (2022)

Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
por: Kovacs, Boldizsar, et al.
Publicado: (2023)

Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer
por: Baron, D., et al.
Publicado: (2023)

Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions
por: Takeda, Atsuya, et al.
Publicado: (2016)

Dose difference between anisotropic analytical algorithm (AAA) and Acuros XB (AXB) caused by target’s air content for volumetric modulated arc therapy of head and neck cancer
por: Ito, Takaaki, et al.
Publicado: (2023)

Maximum diameter versus volumetric assessment for the response evaluation of vestibular schwannomas receiving stereotactic radiotherapy
por: Choi, Youngmin, et al.
Publicado: (2018)

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
por: Karam, Sana D, et al.
Publicado: (2013)

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials
por: Quon, Harvey C., et al.
Publicado: (2016)

Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
por: Vempati, Prashant, et al.
Publicado: (2020)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
por: Liveringhouse, Casey, et al.
Publicado: (2021)

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer
por: Murgic, Jure, et al.
Publicado: (2012)

Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
por: Borgå, Olof, et al.
Publicado: (2019)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
por: Diehl, Christian D., et al.
Publicado: (2019)

Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost
por: Blažek, Tomáš, et al.
Publicado: (2021)

Escalating a Biological Dose of Radiation in the Target Volume Applying Stereotactic Radiosurgery in Patients with Head and Neck Region Tumours
por: Polanowski, Paweł, et al.
Publicado: (2022)

Cumulative radiation doses from recurrent PET–CT examinations
por: Hosono, Makoto, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study
por: Kim, D. W. Nathan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e3s13dv153rq48e6pp14b63j7m